According to the latest financial report of Titan Pharmaceuticals, the latest earnings per share (TTM) for the company is -2.29. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about Titan Pharmaceuticals's free cash flow? The latest report shows it as -2.07M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Titan Pharmaceuticals shows that the company's current ratio is 12.22, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Titan Pharmaceuticals, the quick ratio is 11.60, indicating that the company can meet its short-term debt obligations.
Want to learn more about the financial health of Titan Pharmaceuticals? The latest ROE figure is -41.53%, indicating that the company has stable profitability.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Titan Pharmaceuticals, the total asset return on investment (ROA) is -38.07%.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Titan Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 100.00%.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Titan Pharmaceuticals, the net profit margin is -8.45K%, which is a good sign for its profitability.